| Bioactivity | Fmoc-Thr(GalNAc(Ac)3-β-D)-OH inhibits cancer cell growth, through targeting intricate cancer-specific pathways while simultaneously strengthening immunologic response[1]. |
| Target | others |
| Name | Fmoc-Thr(GalNAc(Ac)3-β-D)-OH |
| CAS | 133575-43-6 |
| Sequence | Fmoc-{Thr(GalNAc(Ac)3-β-D)}-OH |
| Shortening | Fmoc-{Thr(GalNAc(Ac)3-β-D)}-OH |
| Formula | C33H38N2O13 |
| Molar Mass | 670.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Levi S Simpson, et al. Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides. Chem Biol. 2009 Feb 27;16(2):153-61. |
Fmoc-Thr(GalNAc(Ac)3-β-D)-OH
CAS: 133575-43-6 F: C33H38N2O13 W: 670.66
Fmoc-Thr(GalNAc(Ac)3-β-D)-OH inhibits cancer cell growth, through targeting intricate cancer-specific pathways while si
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.